We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Asuragen Launches Mirna Therapeutics to Develop and Commercialize microRNA Oncology Therapeutics

News   Apr 08, 2008

 
Asuragen Launches Mirna Therapeutics to Develop and Commercialize microRNA Oncology Therapeutics
 
 
 

RELATED ARTICLES

CRISPR Screen Identifies Gene That Helps Cells Resist West Nile, Zika Viruses

News

CRISPR used to identify a gene which helps cells resist a nasty class of pathogens.

READ MORE

Day Blind Sheep Cured by Gene Therapy

News

Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.

READ MORE

New Biomarkers Help Decipher When Herpesvirus is Active

News

Researchers have detected certain viral microRNAs which may serve as useful biomarkers under clinical conditions.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE